Health Insurance Costs Anticipated to Rise in 2025
A recent survey by Mercer reveals that U.S. employers expect health insurance costs to rise by an average of 5.8% in 2025. This notable increase stems from escalating medical service costs and a higher demand for healthcare from employees.
Unstoppable Growth in Healthcare Spending
2025 is set to be the third straight year in which healthcare spending for employers surpasses 5%. In comparison, the past decade saw a modest annual increase of just 3%. This trend suggests that employers should prepare for significant healthcare expenses in their plans going forward.
Reasons Behind Rising Costs
Mercer identifies a persistent shortage of healthcare professionals as a key factor driving up medical expenses. This shortage puts pressure on providers, leading to higher prices that employers must cover. Additionally, increased spending on behavioral health services and the rising popularity of costly GLP-1 weight loss medications further contribute to the overall surge in healthcare costs.
Employee contributions expected to stay the same
The percentage of health plan costs that employees cover, currently averaging around 21%, is expected to hold steady in 2025. Beth Umland, who heads employer research for health and benefits at Mercer, notes that while overall costs are climbing, employees may not feel a correspondingly larger financial burden.
Employers Adopting Cost-Management Approaches
Facing these rising expenses, a significant 53% of employers aim to implement cost-management strategies in 2025, up from 44% the year before. These strategies are intended to reduce utilization amongst high-cost members and manage the expenses linked to specialty drugs, which continue to see escalating spending.
Rising Prescription Drug Expenses
Prescription drug costs are rapidly becoming one of the biggest expenses for employers. In 2024, spending on drugs increased by 7.2%, slightly down from an 8.6% rise seen in 2023. As employers struggle with these rising costs, managing drug expenses becomes increasingly vital.
Concerns Regarding Expensive Treatments
Employers are particularly worried about the costs for innovative gene and cellular therapies, some of which can exceed $1 million each. Umland points out that while such treatments are rare, their financial impact can be considerable whenever they appear in claims.
Challenges for Small Employers with Fully Insured Health Plans
Employers with 50 to 499 employees are especially feeling the effects of rising healthcare costs. Without implementing cost-management strategies, these employers could face increases of up to 9%. Those who do take action might still see a rise of 6.3%. Smaller employers often turn to private insurers for fully insured health plans, which typically involve higher premiums, leaving them with few options for cost-saving wellness initiatives, according to Sunit Patel, Mercer's Chief Actuary.
Survey Overview
The recent survey conducted by Mercer includes feedback from 1,800 employers across the United States, encompassing businesses of various sizes—from small companies with just 50 workers to larger corporations with over 500 employees. This data provides a broad view of the challenges and expectations employers face in the intricate healthcare landscape.
Frequently Asked Questions
What is the expected rise in health insurance costs for 2025?
Employers forecast an average increase of 5.8% in health insurance costs for 2025.
What are the major factors contributing to rising healthcare costs?
The primary factors include a shortage of healthcare professionals, rising medical service prices, and increased spending on behavioral health and specialty medications.
How is the employee's share of health plan costs expected to change?
The employee's share of costs, currently around 21%, is anticipated to remain stable in 2025.
What strategies are employers considering to manage healthcare costs?
Employers plan to adopt cost-management strategies focused on high-cost conditions and managing expenses related to specialty drugs.
What concerns do employers have about high-cost treatments?
Employers have concerns regarding the high costs of gene and cellular therapies, which can exceed $1 million, posing a significant challenge to their healthcare budgets.
